UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

The Lancet (British edition), 2014-07, Vol.384 (9938), p.164-172

2014

Volltextzugriff (PDF)

Surrogate marker analysis in cancer clinical trials through time-to-event mediation techniques

Statistical methods in medical research, 2018-11, Vol.27 (11), p.3367-3385

2018

Volltextzugriff (PDF)

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

British journal of cancer, 2019-04, Vol.120 (9), p.913-921

2019

Volltextzugriff (PDF)

Warping Functional Data in R and C via a Bayesian Multiresolution Approach

Journal of statistical software, 2013, Vol.55 (3), p.1-22

2013

Volltextzugriff (PDF)

Multivariate Functional Halfspace Depth

Journal of the American Statistical Association, 2014-03, Vol.109 (505), p.411-423

2014

Volltextzugriff (PDF)

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study

European journal of cancer (1990), 2015-08, Vol.51 (12), p.1497-1510

2015

Volltextzugriff (PDF)

Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: An analysis of the EORTC 10994/BIG 1-00 study

European journal of cancer (1990), 2017-07, Vol.79, p.226-234

2017

Volltextzugriff (PDF)

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

The lancet oncology, 2014-11, Vol.15 (12), p.1303-1310

2014

Volltextzugriff (PDF)

Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

European journal of cancer (1990), 2017-09, Vol.82, p.219-227

2017

Volltextzugriff (PDF)

Therapeutic vaccine JNJ-0535 induces a strong HBV-specific T-cell response in healthy adults and a modest response in chronic HBV-infected patients

Journal of hepatology, 2022-07, Vol.77, p.S72-S73

2022

Volltextzugriff (PDF)

A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults

Antiviral therapy, 2023-06, Vol.28 (3), p.13596535231172878-13596535231172878

2023

Volltextzugriff (PDF)

Phase and amplitude-based clustering for functional data

Computational statistics & data analysis, 2012-07, Vol.56 (7), p.2360-2374

2012

Volltextzugriff (PDF)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JNJ-64794964, a TLR-7 agonist, in healthy adults

Antiviral therapy, 2021-05, Vol.26 (3-5), p.58-68

2021

Volltextzugriff (PDF)

Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants

Antiviral therapy, 2023-02, Vol.28 (1), p.13596535231151626

2023

Volltextzugriff (PDF)

FRI-198-A Phase, double-blind, randomized, placebo-controlled, first-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of oral JNJ-64794964, a toll-like receptor-7 agonist, in healthy adults

Journal of hepatology, 2019-04, Vol.70 (1), p.e478-e478

2019

Volltextzugriff (PDF)

Radiotherapy or surgery for the axilla in node-positive breast cancer? – Authors' reply

The lancet oncology, 2015-02, Vol.16 (2), p.e54-e54

2015

Volltextzugriff (PDF)

Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Modern pathology, 2017-04, Vol.30 (4), p.509-518

2017

Volltextzugriff (PDF)

Abstract 855: p53 isoform Ä133p53â triple negative breast cancer and increased relapse with neoadjuvant taxanes

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.855-855

2016

Volltextzugriff (PDF)

Abstract 855: p53 isoform 133p53 triple negative breast cancer and increased relapse with neoadjuvant taxanes

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.855-855

2016

Volltextzugriff (PDF)

Correlation between severe infection and breast cancer metastases in the EORTC 10994/BIG 1-00 trial: Investigating innate immunity as a tumour suppressor in breast cancer

European journal of cancer (1990), 2017-02, Vol.72, p.95-102

2017

Volltextzugriff (PDF)

multiresolution approach to time warping achieved by a Bayesian prior-posterior transfer fitting strategy

Journal of the Royal Statistical Society. Series B, Statistical methodology, 2010-11, Vol.72 (5), p.673-694

2010

Volltextzugriff (PDF)

Immune Mediated Protection in Multiple Sclerosis: A Role for Neurokines in Oligodendrocyte Survival and Macrophage Modulation

Clinical immunology (Orlando, Fla.), 2007-01, Vol.123, p.S137-S137

2007

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(42)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Humans
(15)
Life Sciences & Biomedicine
(15)
Breast Cancer
(12)
Female
(10)
Adult
(9)
Middle Aged
(9)
Oncology
(9)
Aged
(7)
Breast Neoplasms - Drug Therapy
(6)
Breast Neoplasms - Pathology
(6)
Chemotherapy
(6)
Hematology, Oncology And Palliative Medicine
(6)
Tumors
(6)
Breast Neoplasms - Surgery
(5)
Cancer
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Breast Neoplasms - Genetics
(4)
Cancer Therapies
(4)
Chemotherapy, Adjuvant
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

Surrogate marker analysis in cancer clinical trials through time-to-event mediation techniques

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

Warping Functional Data in R and C via a Bayesian Multiresolution Approach

Multivariate Functional Halfspace Depth

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study

Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: An analysis of the EORTC 10994/BIG 1-00 study

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

LBP-005 Efficacy, safety, tolerability, and immunogenicity of JNJ-0535 following a reduction of viral antigen levels through administration of siRNA JNJ-3989 in patients with chronic HBeAg negative hepatitis B-interim data of the OSPREY study

Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Therapeutic vaccine JNJ-0535 induces a strong HBV-specific T-cell response in healthy adults and a modest response in chronic HBV-infected patients

A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults

Phase and amplitude-based clustering for functional data

Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JNJ-64794964, a TLR-7 agonist, in healthy adults

Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants

FRI-198-A Phase, double-blind, randomized, placebo-controlled, first-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of oral JNJ-64794964, a toll-like receptor-7 agonist, in healthy adults

Radiotherapy or surgery for the axilla in node-positive breast cancer? – Authors' reply

Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial

Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Abstract 855: p53 isoform Ä133p53â triple negative breast cancer and increased relapse with neoadjuvant taxanes

Abstract 855: p53 isoform 133p53 triple negative breast cancer and increased relapse with neoadjuvant taxanes

Correlation between severe infection and breast cancer metastases in the EORTC 10994/BIG 1-00 trial: Investigating innate immunity as a tumour suppressor in breast cancer

multiresolution approach to time warping achieved by a Bayesian prior-posterior transfer fitting strategy

Immune Mediated Protection in Multiple Sclerosis: A Role for Neurokines in Oligodendrocyte Survival and Macrophage Modulation

Suchergebnisse filtern